Previously untreatable lung cancer patients offered new therapy
NICE document recommends Amgen’s Lumykras (sotorasib) to treat non-small-cell lung cancer
Read More
Author: John Pinching
Clinical jobs increase as R&D and lab roles experience record growth
The post-Brexit landscape has witnessed an exponential boom in life science careers
Read More
Novartis’ Kesimpta trial provides positive results for MS patients
MS patients given boost by results of study into Kesimpta – a self-administered treatment with potential to improve lives
Read More
Brain Training: BioMed X Institute collaborates with Boehringer Ingelheim
Sensor development project marks the fifth joint research effort between BioMed X with Boehringer Ingelheim
Read More
CHMP recommends Idorsia’s dual acting treatment Quviviq for insomnia patients
Quviviq can be used on a long-term basis, addressing a key limitation of existing therapies
Read More- NICE backs daratumumab quadruplet for newly diagnosed transplant‑ineligible myeloma
- Anocca doses first patients with precision TCR‑T therapy
- Connecta launches phase 2a trial of neuroplasticity modulator
- Aquipta recommended by NICE for acute migraine treatment
- Talvey accepted for use in Scotland for relapsed and refractory multiple myeloma
